IPO Issue Details
Issue Price / Price Band₹248 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size600 Shares per Lot
Total Issue Size32,29,200 shares (aggregating up to ₹80.08 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenMon, 07 Jul 2025
Subscription CloseWed, 09 Jul 2025
Anchor AllotmentSun, 06 Jul 2025
Basis of AllotmentThu, 10 Jul 2025
Initiation of RefundsFri, 11 Jul 2025
Credit of Shares to DematFri, 11 Jul 2025
Listing DateMon, 14 Jul 2025
UPI Mandate Deadline2025-07-09
Application & Investment Details
Retail — Min (2 Lots)₹2,97,600 — 1200 shares
Retail — Max (13 Lots)₹1,934,400 (13 Lots)
HNI — Min (3 Lots)₹4,46,400 — 1800 shares
EPS (Pre-IPO)₹25.54
EPS (Post-IPO)₹20.05
P/E Ratio (Pre-IPO)9.71x
P/E Ratio (Post-IPO)12.37x
Net Offer to Public30,63,000 shares (aggregating up to ₹75.96 Cr)
Reserved for Market Maker1,66,200 shares (aggregating up to ₹4.12 Cr)
Pre-IPO Promoter Holding94,99,000 shares
Post-IPO Promoter Holding1,20,99,000 shares
Fresh Issue Shares24,33,800 shares (aggregating up to ₹60.36 Cr)
Offer for Sale Shares6,29,200 shares of ₹10 (aggregating up to ₹15.60 Cr)
About Chemkart India Ltd.
Incorporated in 2015, Chemkart India Limited is a distributor specializing in high-quality food and health ingredients. The company bridges the gap between global ingredient manufacturers and businesses across various sectors.The company targets the B2B platform, providing products for manufacturing supplements like sports, health, vitamins, and protein. Focused on variety, affordability, quality, and customer relationships, it enhances supply chain processes.The company provides grinding, blending, and packaging services at its hygienic facility in Bhiwandi, Mumbai. The 28,259.16 sq. ft. warehouse is equipped for efficient processing, labeling, and sealing of ingredients.Products Portfolio:Amino Acid: The Building blocks of proteins essential for biological processes and metabolism.Health Supplement: Supplements with essential nutrients and bioactive compounds for wellbeing.Herbal Extract: Extracts from plants used for therapeutic and functional benefits.Nucleotide: Key components supporting immune health, gut health, and nutrition.Protein: Vital for muscle growth, immune function, and overall health.Sports Nutrition: Ingredients supporting athletic performance, endurance, and recovery.Vitamins: Micronutrients essential for various bodily physiological functions.As of March 31, 2025, the company had 40 employees.Competitive Strengths:Diversified product portfolioIn house processing and warehousing capabilitiesValue proposition for Customers
Objects of the Issue
Chemkart India Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Financing the capital expenditure towards setting up of the Manufacturing Facility through investment in the Wholly-Owned Subsidiary (WOS) Company, Easy Raw Materials Private Limited
34.68
2
2 Repayment/prepayment of all or certain of the borrowings availed of by the Company
20.00
3
3 General Corporate Purpose
0.27
Shareholding & Lock-in
Pre-IPO Promoter Holding
94,99,000 shares
Post-IPO Promoter Holding
1,20,99,000 shares